首页
产品目录
分子砌块
按官能团
醇类
(2S,4R)-N-((S)-3-((11-(4-(3-((4-((3-氯-4-氟苯基)氨基)-7-甲氧基喹唑啉-6-基)氧)丙基)哌嗪-1-基)-11-氧代十一烷基)氨基)-1-(4-(4-甲基噻唑-5-基)苯基)-3-氧代丙基)-4-羟基-1-((R)-3-甲基-2-(3-甲基异噁唑-5-基)丁酰基)吡咯烷-2-甲酰胺
(2S,4R)-N-((S)-3-((11-(4-(3-((4-((3-氯-4-氟苯基)氨基)-7-甲氧基喹唑啉-6-基)氧)丙基)哌嗪-1-基)-11-氧代十一烷基)氨基)-1-(4-(4-甲基噻唑-5-基)苯基)-3-氧代丙基)-4-羟基-1-((R)-3-甲基-2-(3-甲基异噁唑-5-基)丁酰基)吡咯烷-2-甲酰胺
(2S,4R)-N-((S)-3-((11-(4-(3-((4-((3-Chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)propyl)piperazin-1-yl)-11-oxoundecyl)amino)-1-(4-(4-methylthiazol-5-yl)phenyl)-3-oxopropyl)-4-hydroxy-1-((R)-3-methyl-2-(3-methylisoxazol-5-yl)butanoyl)pyrrolidine-2-carboxamide
产品编号 :
ACQJCF558
Cas No. :
2772612-96-9
包装规格
纯度
目录价
会员专享价
库存
数量
1mg
98%
¥3811
询价
晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。
基础信息
CAS No.
2772612-96-9
中文名称
(2S,4R)-N-((S)-3-((11-(4-(3-((4-((3-氯-4-氟苯基)氨基)-7-甲氧基喹唑啉-6-基)氧)丙基)哌嗪-1-基)-11-氧代十一烷基)氨基)-1-(4-(4-甲基噻唑-5-基)苯基)-3-氧代丙基)-4-羟基-1-((R)-3-甲基-2-(3-甲基异噁唑-5-基)丁酰基)吡咯烷-2-甲酰胺
英文名称
(2S,4R)-N-((S)-3-((11-(4-(3-((4-((3-Chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)propyl)piperazin-1-yl)-11-oxoundecyl)amino)-1-(4-(4-methylthiazol-5-yl)phenyl)-3-oxopropyl)-4-hydroxy-1-((R)-3-methyl-2-(3-methylisoxazol-5-yl)butanoyl)pyrrolidine-2-carboxamide
别名
MS9449
标准英文名
(2S,4R)-N-((S)-3-((11-(4-(3-((4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)propyl)piperazin-1-yl)-11-oxoundecyl)amino)-1-(4-(4-methylthiazol-5-yl)phenyl)-3-oxopropyl)-4-hydroxy-1-((R)-3-methyl-2-(3-methylisoxazol-5-yl)butanoyl)pyrrolidine-2-carboxamide
分子式
C6 0 H7 6 ClFN1 0 O8 S
分子量
1151.85
精确分子量
1150.52
SMILES
O=C([C@H](C(C)C)C1=CC(C)=NO1)N2C[C@H](O)C[C@H]2C(N[C@H](C3=CC=C(C4=C(C)N=CS4)C=C3)CC(NCCCCCCCCCCC(N5CCN(CCCOC6=CC7=C(NC8=CC=C(F)C(Cl)=C8)N=CN=C7C=C6OC)CC5)=O)=O)=O
标准SMILES
CC(C)[C@H](C1=CC(C)=NO1)C(=O)N1C[C@H](O)C[C@H]1C(=O)N[C@@H](CC(=O)NCCCCCCCCCCC(=O)N1CCN(CCCOC2=CC3=C(NC4=CC=C(F)C(Cl)=C4)N=CN=C3C=C2OC)CC1)C1=CC=C(C=C1)C1SC=NC=1C
用途
MS9449 can be used in anticancer research; it exhibits potent inhibition of NSCLC cell proliferation and effectively induces degradation of mutant EGFRs via the ubiquitin/proteasome system (UPS) and the autophagy/lysosome pathway.
InChIKey
VDUPETHSNLCFNB-HHHFUCLFSA-N